Sakineh Ansari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sakineh Ansari has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Ali Hajigholami
Internal Medicine, Division of Hematology and Oncology, School of Medicine Isfahan University of Medical Sciences Isfahan Iran
2 shared publications - Hourieh Ansari
Department of Community and Family Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 shared publications - Shakiba Hassanzadeh
Division of Pathology, Nickan Research Institute, Isfahan, Iran
2 shared publications
Latest Publications
- Open Access
- 18 December 2021
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 11 (2) , e10453
Acquired hemophilia in a patient with SARS-CoV-2 infection; a case report
Acquired hemophilia (AH) is a potentially life-threatening hemorrhagic disorder. We report the second confirmed case of COVID-19-associated AH in a 45-year-old female which, unfortunately, expired as her treatment failed. She presented to the emergency department with abnormal bleeding and spontaneous hemoptysis about ten days after a removal surgery of her epiglottis tumor. Aggregation tests, such as partial thromboplastin time (PTT), are recommended in patients with COVID-19 infection that have bleeding episodes.
- 18 December 2021
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 11 (2) , e10453
Open AccessAcquired hemophilia in a patient with SARS-CoV-2 infection; a case report
Acquired hemophilia (AH) is a potentially life-threatening hemorrhagic disorder. We report the second confirmed case of COVID-19-associated AH in a 45-year-old female which, unfortunately, expired as her treatment failed. She presented to the emergency department with abnormal bleeding and spontaneous hemoptysis about ten days after a removal surgery of her epiglottis tumor. Aggregation tests, such as partial thromboplastin time (PTT), are recommended in patients with COVID-19 infection that have bleeding episodes.
- Open Access
- 18 December 2021
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 12 (1) , e10454
COVID-19-associated thrombotic thrombocytopenic purpura (TTP); a case report
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease (COVID-19) pandemic is the largest infectious crisis in the present century. It has been reported that COVID-19 infection may trigger autoimmune diseases. Herein, we report a 68-year-old male that was diagnosed with thrombotic thrombocytopenic purpura (TTP) following COVID-19 infection. To our knowledge, this is the fourth case of COVID-19-associated TTP. More attention is required regarding the possibility of developing TTP in COVID-19 patients, especially with the presence of decreased consciousness and low levels of hemoglobin and platelet.
- 18 December 2021
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 12 (1) , e10454
Open AccessCOVID-19-associated thrombotic thrombocytopenic purpura (TTP); a case report
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease (COVID-19) pandemic is the largest infectious crisis in the present century. It has been reported that COVID-19 infection may trigger autoimmune diseases. Herein, we report a 68-year-old male that was diagnosed with thrombotic thrombocytopenic purpura (TTP) following COVID-19 infection. To our knowledge, this is the fourth case of COVID-19-associated TTP. More attention is required regarding the possibility of developing TTP in COVID-19 patients, especially with the presence of decreased consciousness and low levels of hemoglobin and platelet.